var data={"title":"Neurologic manifestations of rheumatoid arthritis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Neurologic manifestations of rheumatoid arthritis</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/contributors\" class=\"contributor contributor_credentials\">Monica L Piecyk, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/contributors\" class=\"contributor contributor_credentials\">Peter H Schur, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/contributors\" class=\"contributor contributor_credentials\">Ravinder N Maini, BA, MB BChir, FRCP, FMedSci, FRS</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/contributors\" class=\"contributor contributor_credentials\">Paul L Romain, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Mar 16, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Rheumatoid arthritis (RA) is associated with various nonarticular manifestations, including a range of rare neurologic abnormalities. Additionally, neuromuscular and muscular disorders may also occur, and medications used in RA may have adverse neurologic effects.</p><p>Neurologic and muscular disorders associated with RA will be reviewed here. Other nonarticular and non-neurologic problems associated with RA are presented separately, as are detailed discussions of the clinical manifestations, diagnosis, and treatment of rheumatoid vasculitis. (See <a href=\"topic.htm?path=overview-of-the-systemic-and-nonarticular-manifestations-of-rheumatoid-arthritis\" class=\"medical medical_review\">&quot;Overview of the systemic and nonarticular manifestations of rheumatoid arthritis&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-rheumatoid-vasculitis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of rheumatoid vasculitis&quot;</a> and <a href=\"topic.htm?path=treatment-of-rheumatoid-vasculitis\" class=\"medical medical_review\">&quot;Treatment of rheumatoid vasculitis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H687641716\"><span class=\"h1\">CLASSIFICATION AND EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Neurologic and neuromuscular complications of rheumatoid arthritis (RA) may occur by several mechanisms, including direct effects of compression or invasion of neural tissues and as a consequence of vasculitic neuropathy. Rheumatoid synovitis and pannus may compress or invade adjacent structures (including the spinal cord and peripheral nerves), resulting in myelopathy, radiculopathy, and entrapment neuropathies. Vasculitic neuropathy is a frequent component of rheumatoid vasculitis; the neuropathy in these patients results from infarction of individual peripheral nerves by vasculitis in the vasa nervorum [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/1,2\" class=\"abstract_t\">1,2</a>].</p><p>With peripheral nervous system involvement due to rheumatoid vasculitis, there may be multiple nerve dysfunction (mononeuritis multiplex) or a more indolent polyneuropathy. Approximately 40 percent of patients with RV have a sensory neuropathy, and up to 20 percent develop manifestations of a mixed motor or sensory neuropathy [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/1,3\" class=\"abstract_t\">1,3</a>]. Both mononeuritis multiplex and a distal symmetric sensory or sensorimotor neuropathy can occur [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/1,3,4\" class=\"abstract_t\">1,3,4</a>]. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-rheumatoid-vasculitis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of rheumatoid vasculitis&quot;</a>.)</p><p>Central nervous system (CNS) involvement is uncommon, but may cause ischemia, infarction, or bleeding that may result in transient ischemic attacks, stroke, quadriplegia, or paraparesis. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-rheumatoid-vasculitis#H5\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of rheumatoid vasculitis&quot;, section on 'Neurologic disease'</a>.)</p><p>The introduction of newer medications since the 1990s, along with more aggressive and effective strategies for the treatment of RA, appears to have reduced the frequency with which some of the neurologic and other extra-articular manifestations of RA are observed [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/5-7\" class=\"abstract_t\">5-7</a>].</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">CENTRAL NERVOUS SYSTEM</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Disorders of the central nervous system (CNS) due to rheumatoid arthritis (RA) include cervical myelopathy, vasculitis, rheumatoid nodules located within the CNS, meningitis, organic brain syndrome, and (rarely) progressive multifocal leukoencephalopathy. Stroke also occurs with increased frequency, but the basis for this association is not well understood.</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Cervical myelopathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cervical myelopathy (cervical myeloradiculopathy) resulting from atlantoaxial subluxation, atlantoaxial impaction, <span class=\"nowrap\">and/or</span> subaxial subluxation is discussed separately. (See <a href=\"topic.htm?path=cervical-subluxation-in-rheumatoid-arthritis\" class=\"medical medical_review\">&quot;Cervical subluxation in rheumatoid arthritis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Central nervous system vasculitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>CNS vasculitis is rare in patients with RA, with the literature generally consisting of case reports of intracranial arteritis [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/8-15\" class=\"abstract_t\">8-15</a>]. CNS lesions are also infrequent in patients with systemic rheumatoid vasculitis [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/3,15,16\" class=\"abstract_t\">3,15,16</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h3\">Clinical manifestations</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Presenting manifestations of CNS vasculitis include seizures, dementia, cranial nerve palsies, strokes, encephalopathy, intracerebral or subarachnoid hemorrhage, and myelopathy.</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h3\">Diagnosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Brain biopsy is the most specific diagnostic test. Cerebral angiography and magnetic resonance angiogram also may be helpful but are less specific. However, some evidence suggests that magnetic resonance imaging (MRI) abnormalities among symptomatic patients with RA cannot be ascribed to vasculitis alone. One study, for example, evaluated the incidence of hyperintense white matter lesions with MRI, findings suggestive of vasculitis, in 33 asymptomatic patients with RA and 48 control individuals [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/17\" class=\"abstract_t\">17</a>]. There was no significant difference in the number of such lesions between the two groups.</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h3\">Treatment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Therapy of patients with RA and CNS vasculitis is similar to that for patients with isolated CNS vasculitis. This includes high-dose glucocorticoids and cytotoxic agents. (See <a href=\"topic.htm?path=primary-angiitis-of-the-central-nervous-system-in-adults\" class=\"medical medical_review\">&quot;Primary angiitis of the central nervous system in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Rheumatoid nodules</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Rheumatoid nodules have been reported rarely in the central nervous system [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/18,19\" class=\"abstract_t\">18,19</a>]. Extradural nodules in the spinal canal may cause nerve root compression, spinal cord compression, and spinal stenosis [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/20,21\" class=\"abstract_t\">20,21</a>].</p><p>Rheumatoid nodules of the cerebral leptomeninges and within the choroid plexus also have been described [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/13,22-25\" class=\"abstract_t\">13,22-25</a>]. Neurologic signs and symptoms in these patients have not always correlated with the anatomic location of the nodules; in many cases, there was coexistent CNS pathology.</p><p>Most patients with CNS nodules have severe erosive joint disease, other extraarticular features, and high titer rheumatoid factors [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/20,23,25\" class=\"abstract_t\">20,23,25</a>]. In reported cases, the diagnosis of CNS rheumatoid nodules was made pathologically, either at surgery or autopsy.</p><p>Surgical decompression should be performed if a rheumatoid nodule is compressing a vital structure.</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Meningitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Rheumatoid meningitis consists of an inflammatory infiltrate of the meninges without distinct rheumatoid nodules [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/18,26-29\" class=\"abstract_t\">18,26-29</a>]. Most patients have longstanding seropositive disease. Symptoms may include altered mental status, fever, headaches, seizures, cranial nerve dysfunction, and hemiparesis or paraparesis. Elevated cerebrospinal fluid levels of protein are the most common abnormality, but pleocytosis and depressed glucose also are described. In several case reports, treatment with glucocorticoids resulted in improvement in neurologic symptoms [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/28,29\" class=\"abstract_t\">28,29</a>].</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Organic brain syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Manifestations of organic brain syndrome (OBS), including confusion, memory loss, and seizures, have been described in six RA patients being treated with no or low-dose glucocorticoids [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/30\" class=\"abstract_t\">30</a>]. However, it is unknown whether the OBS was actually due to RA. Four were treated with high-dose steroid therapy. All six patients, including those who were observed without therapy, improved within one week.</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Progressive multifocal leukoencephalopathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The risk of progressive multifocal leukoencephalopathy (PML), which is associated with the polyoma JC virus, is increased in patients treated with <a href=\"topic.htm?path=rituximab-intravenous-drug-information\" class=\"drug drug_general\">rituximab</a> for RA, but the absolute risk is very small. PML was reported in two patients with RA prior to the use of biologic disease-modifying antirheumatic drugs (DMARDs) [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/31\" class=\"abstract_t\">31</a>]. A case was also reported in a patient with RA on rituximab and other immunosuppressive therapies, who was also treated for a malignancy [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/32\" class=\"abstract_t\">32</a>]. There has been at least one case reported in association with use of <a href=\"topic.htm?path=adalimumab-including-biosimilars-of-adalimumab-drug-information\" class=\"drug drug_general\">adalimumab</a> in RA [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/33\" class=\"abstract_t\">33</a>]. There was one case of leukoencephalopathy in a RA patient treated with <a href=\"topic.htm?path=methotrexate-drug-information\" class=\"drug drug_general\">methotrexate</a> [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/34\" class=\"abstract_t\">34</a>]. In patients with RA treated with rituximab, at least four cases of PML have been reported to regulatory agencies [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/35\" class=\"abstract_t\">35</a>]. The estimated absolute risk of PML is one case per 25,000 patients with RA treated with rituximab [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/36\" class=\"abstract_t\">36</a>]. In an observational study using a nationwide inpatient sample database in the United States, the rate of PML in hospitalized patients with RA was estimated at 0.4 per 100,000 discharges, twice the rate in the background population [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/37\" class=\"abstract_t\">37</a>]. (See <a href=\"topic.htm?path=progressive-multifocal-leukoencephalopathy-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Progressive multifocal leukoencephalopathy: Epidemiology, clinical manifestations, and diagnosis&quot;</a> and <a href=\"topic.htm?path=overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections\" class=\"medical medical_review\">&quot;Overview of JC polyomavirus, BK polyomavirus, and other polyomavirus infections&quot;</a> and <a href=\"topic.htm?path=rituximab-and-other-b-cell-targeted-therapies-for-rheumatoid-arthritis#H16\" class=\"medical medical_review\">&quot;Rituximab and other B cell targeted therapies for rheumatoid arthritis&quot;, section on 'Hypogammaglobulinemia and infection'</a>.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Hyperviscosity syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hyperviscosity may cause symptoms similar to those seen in patients with Waldenstr&ouml;m&rsquo;s macroglobulinemia [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/38\" class=\"abstract_t\">38</a>]. The clinical manifestations of hyperviscosity include headache, visual changes, vertigo, tinnitus, hearing loss, and cognitive dysfunction. This syndrome is discussed in more detail elsewhere. (See <a href=\"topic.htm?path=epidemiology-pathogenesis-clinical-manifestations-and-diagnosis-of-waldenstrom-macroglobulinemia#H7\" class=\"medical medical_review\">&quot;Epidemiology, pathogenesis, clinical manifestations, and diagnosis of Waldenstr&ouml;m macroglobulinemia&quot;, section on 'Hyperviscosity syndrome'</a>.)</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Stroke</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There is an increased risk of stroke in RA, especially ischemic stroke. A 2008 meta-analysis, involving 111,758 patients in 24 studies, found a significant increase in the risk of death from cerebrovascular accidents in patients with RA, compared with the general population (weighted-pooled summary estimate of standardized mortality ratios of 1.52, 95% CI 1.40-1.67) [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/39\" class=\"abstract_t\">39</a>]. Significant heterogeneity, however, was found between the studies analyzed, and some studies have not shown stroke to be increased [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/40\" class=\"abstract_t\">40</a>]. The following are examples of three large individual studies that have addressed the risk of stroke in RA:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The magnitude of this effect was illustrated in a nested case-control analyses within a longitudinal data bank of 16,990 patients with RA compared with 5140 patients with noninflammatory rheumatic disease, 226 first strokes, of which 59 were ischemic, occurred in the RA patients (odds ratio 1.64 for all first strokes, 95% CI 1.16-2.30, and 2.66 for ischemic strokes, 95% CI 1.24-5.70) [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/41\" class=\"abstract_t\">41</a>]. Risk factors for ischemic stroke included severity of RA, hypertension, myocardial infarction, and low-dose <a href=\"topic.htm?path=aspirin-drug-information\" class=\"drug drug_general\">aspirin</a> use, but not diabetes, smoking, exercise, or body mass index. Treatment with rofecoxib and possibly antecedent treatment with glucocorticoids were other possible risk factors.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A significant increase in stroke was also noted in a population based study of 25,385 Canadian adults with RA, which evaluated the incidence of cardiovascular events (including myocardial infarction, stroke, or cardiovascular death) compared with age- and sex-matched controls [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/42\" class=\"abstract_t\">42</a>]. The patients with RA had a small but significant absolute increase in stroke risk (2.4 per 1000 person-years, rate ratio 1.9, 95% CI 1.7-2.1). The absolute increase in cardiovascular events in RA patients was much greater in those over age 65.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>A nationwide Danish cohort study involving 18,247 patients with RA followed for a median of 4.8 years identified 718 strokes in patients with RA, representing a significant absolute increase in stroke risk compared with the general population (1.9 per 1000 person-years, with an adjusted incidence rate ratio of 1.32, 95% CI 1.22-1.42) [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/43\" class=\"abstract_t\">43</a>]. This study also demonstrated an increased risk of atrial fibrillation in patients with RA, but the degree to which this contributed to stroke risk was not determined. (See <a href=\"topic.htm?path=overview-of-the-systemic-and-nonarticular-manifestations-of-rheumatoid-arthritis#H187567760\" class=\"medical medical_review\">&quot;Overview of the systemic and nonarticular manifestations of rheumatoid arthritis&quot;, section on 'Atrial fibrillation'</a>.)</p><p/><p>Patients with RA also have an increased risk of coronary artery disease. (See <a href=\"topic.htm?path=coronary-artery-disease-in-rheumatoid-arthritis-pathogenesis-risk-factors-clinical-manifestations-and-diagnostic-implications\" class=\"medical medical_review\">&quot;Coronary artery disease in rheumatoid arthritis: Pathogenesis, risk factors, clinical manifestations, and diagnostic implications&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">PERIPHERAL NERVOUS SYSTEM</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Compression neuropathies are the most common neurologic manifestation of rheumatoid arthritis (RA). Sensory and motor dysfunction may also occur due to noncompressive neuropathies and myopathies.</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h2\">Compression or entrapment neuropathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Entrapment neuropathies are diagnosed in approximately one-half of RA patients with severe peripheral disease and subcutaneous nodules [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/44\" class=\"abstract_t\">44</a>]. Joint deformities and inflamed synovium, ligaments, or tendon sheaths may compress peripheral nerves that are in close proximity to joints or bursae. There is no correlation between compression neuropathies and gender, duration of RA, functional class, the presence of other extraarticular disease, seropositivity, or the level of acute phase reactants [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/45\" class=\"abstract_t\">45</a>].</p><p>Electromyography (EMG), magnetic resonance imaging (MRI), and ultrasonography are the most useful tests for evaluating compression of peripheral nerves [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/46,47\" class=\"abstract_t\">46,47</a>].</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h3\">Carpal tunnel syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Carpal tunnel syndrome (CTS) is probably the most common neurologic manifestation of RA and can occur at any time during the disease [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/9,44,48,49\" class=\"abstract_t\">9,44,48,49</a>]. In different series, CTS occurred in 23 to 69 percent of patients [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/45,50-52\" class=\"abstract_t\">45,50-52</a>]. The probable cause of CTS is finger-flexor tenosynovitis, since these tendons also pass through the carpal tunnel.</p><p>Symptoms, findings, neurodiagnostic testing, and differential diagnosis of CTS in patients with RA is similar to that for other patients. (See <a href=\"topic.htm?path=carpal-tunnel-syndrome-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Carpal tunnel syndrome: Clinical manifestations and diagnosis&quot;</a> and <a href=\"topic.htm?path=carpal-tunnel-syndrome-etiology-and-epidemiology\" class=\"medical medical_review\">&quot;Carpal tunnel syndrome: Etiology and epidemiology&quot;</a>.)</p><p>Conservative and surgical therapies are also similar and are discussed separately. (See <a href=\"topic.htm?path=carpal-tunnel-syndrome-treatment-and-prognosis\" class=\"medical medical_review\">&quot;Carpal tunnel syndrome: Treatment and prognosis&quot;</a> and <a href=\"topic.htm?path=surgery-for-carpal-tunnel-syndrome\" class=\"medical medical_review\">&quot;Surgery for carpal tunnel syndrome&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h3\">Tarsal tunnel syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Tarsal tunnel syndrome, which is less common than CTS, is due to compression of the posterior tibial nerve as it passes near the medial malleolus [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/44,53,54\" class=\"abstract_t\">44,53,54</a>]. Tarsal tunnel syndrome may result from tenosynovitis, inflammation of the flexor retinaculum, valgus deformities, adjacent bone fracture or dislocation, or posttraumatic edema and fibrosis. Symptoms include paresthesia and pain in the sole of the foot and the first through third toes. Findings of atrophy and weakness of the intrinsic foot muscles occur with more advanced disease. From 5 to 25 percent of RA patients have electrophysiologic abnormalities characteristic of tarsal tunnel syndrome, although not all of these patients are symptomatic [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/55-57\" class=\"abstract_t\">55-57</a>].</p><p>Treatment of the tarsal tunnel syndrome in patients with RA is similar to the approach for other patients.</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h3\">Other compression neuropathies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Although unusual, compression of other peripheral nerves has been reported in patients with RA. Affected nerves include the anterior and posterior interosseous, ulnar, common peroneal, and tibial [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/44,48,49,53,54,58,59\" class=\"abstract_t\">44,48,49,53,54,58,59</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>An entrapment neuropathy and symptomatic cervical spine disease with nerve root compression may present concurrently and is termed the &quot;double crush&quot; syndrome [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/44\" class=\"abstract_t\">44</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The common peroneal and tibial nerves may be compressed by a popliteal cyst. (See <a href=\"topic.htm?path=popliteal-bakers-cyst\" class=\"medical medical_review\">&quot;Popliteal (Baker's) cyst&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H19\"><span class=\"h3\">Treatment of compression neuropathies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nonsurgical management involves treatment of the underlying disease process. Additional modalities include splints, antiinflammatory medications, and local corticosteroid injections. Surgical decompression is indicated if motor deficits or denervation are present, or if sensory symptoms worsen despite adequate nonsurgical therapy [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/56,59\" class=\"abstract_t\">56,59</a>].</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h2\">Noncompression neuropathies</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Neuropathic abnormalities detected by nerve conduction studies (NCS) and EMG studies are reportedly more common in patients with RA than in controls [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/60\" class=\"abstract_t\">60</a>]. Distal sensory neuropathy and sensorimotor neuropathy have been reported in 1 to 18 percent of patients [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/52\" class=\"abstract_t\">52</a>]. Vasculopathy and vasculitis have been implicated in the pathogenesis of these neuropathies [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/3,49,58,61-63\" class=\"abstract_t\">3,49,58,61-63</a>].</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h3\">Distal sensory neuropathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Peripheral sensory polyneuropathy, which typically presents in a slowly progressive fashion, has the following additional clinical features:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Symptoms may be difficult to distinguish from those due to arthritis [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/49,61\" class=\"abstract_t\">49,61</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Symmetric paresthesias and burning sensations tend to be worse in the feet than in the hands [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/49,61,64\" class=\"abstract_t\">49,61,64</a>].</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Vibratory, pinprick, and light touch sensation are decreased, while proprioception is spared.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Reflexes may be lost, and both sensory and motor nerve conduction studies may be abnormal [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/61,63\" class=\"abstract_t\">61,63</a>].</p><p/><p>In one study of 25 patients, neuropathy usually developed after the arthritis, and there was no relation between duration of RA and neuropathy [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/61\" class=\"abstract_t\">61</a>]. Studies employing sural nerve biopsy reveal mild proliferative endarteritis or normal vasculature with segmental demyelination and remyelination with areas of axonal degeneration [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/62,63\" class=\"abstract_t\">62,63</a>]. There is mild loss of predominantly large myelinated fibers [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/48,61\" class=\"abstract_t\">48,61</a>]. The yield of biopsy may be low, given the mild pathological changes and patchy distribution of lesions.</p><p>Overall, distal sensory neuropathy has a good prognosis. It is uncommon for patients to progress to a more severe neuropathy [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/58,61\" class=\"abstract_t\">58,61</a>]. In most patients, the severity of neuropathy is not altered with steroid therapy; 75 percent of patients recover partially or completely.</p><p class=\"headingAnchor\" id=\"H22\"><span class=\"h3\">Combined sensorimotor neuropathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Combined sensorimotor neuropathy is associated with long duration seropositive, nodular RA, male gender, other extraarticular involvement, systemic constitutional symptoms, and other signs of vasculitis including palpable purpura, livedo reticularis, skin ulcerations, nailfold and digital infarcts, and Raynaud phenomenon [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/3,32,49,58,61,63-65\" class=\"abstract_t\">3,32,49,58,61,63-65</a>]. High rheumatoid factor titers, a polyclonal increase in immunoglobulins, and low complement levels are also common.</p><p>Combined sensorimotor neuropathy is more severe and presents more acutely than distal sensory neuropathy [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/49,61\" class=\"abstract_t\">49,61</a>]. Symptoms include significant asymmetric pain and paresthesias. Weakness may develop within hours to days of the initial onset of symptoms. Wrist and foot drops are most common, and deep tendon reflexes are decreased or absent. Asymptomatic sensorimotor neuropathy may be more common, being reported in one series in <span class=\"nowrap\">26/40</span> patients studied [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/66\" class=\"abstract_t\">66</a>]. Mononeuritis multiplex or a polyneuropathy have been reported. Electrophysiologic studies demonstrate axonal degeneration or severe demyelination [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/61,63\" class=\"abstract_t\">61,63</a>]. These findings are suggestive of nerve damage due to vasculitis. (See <a href=\"topic.htm?path=diagnosis-and-treatment-of-vasculitic-neuropathy\" class=\"medical medical_review\">&quot;Diagnosis and treatment of vasculitic neuropathy&quot;</a>.)</p><p>The following observations relate to vasculitic neuropathy seen specifically in patients with RA:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Arterial pathology of affected peripheral nerves includes fibrinoid necrosis of the media with infiltration by polymorphonuclear leukocytes, eosinophils, and mononuclear cells. Perivascular infiltration with mononuclear cells, intimal proliferation with minimal cellular infiltrates, <span class=\"nowrap\">and/or</span> fibrosis also can be observed [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/63\" class=\"abstract_t\">63</a>]. Vasculitis of the epineural arteries results in vessel ischemia with resulting axonal degeneration and neuronal demyelination [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/53,63\" class=\"abstract_t\">53,63</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The arteritis may be immune complex-mediated. Sural nerve examination has demonstrated IgG, IgM, complement, and fibrin depositions in areas of acute necrotizing arteritis, while these deposits are usually absent in vessels without acute inflammation [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/64\" class=\"abstract_t\">64</a>].</p><p/><p>There is no standard treatment regimen for this neuropathy. Patients have been treated as for immune complex-mediated necrotizing vasculitis [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/53\" class=\"abstract_t\">53</a>]. Both corticosteroids and <a href=\"topic.htm?path=cyclophosphamide-drug-information\" class=\"drug drug_general\">cyclophosphamide</a>, in oral doses and intravenous pulses, have been used. Small case series and case reports document successful treatment of rheumatoid vasculitis with tumor necrosis factor inhibitors (see <a href=\"topic.htm?path=treatment-of-rheumatoid-vasculitis\" class=\"medical medical_review\">&quot;Treatment of rheumatoid vasculitis&quot;</a>). There is no convincing evidence that steroids are helpful or that antimalarials and gold alter the course of disease [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/49,61\" class=\"abstract_t\">49,61</a>]. Plasmapheresis has been used in refractory cases, but without great success [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/65\" class=\"abstract_t\">65</a>].</p><p>Combined sensorimotor neuropathy has a poor prognosis, with most patients progressively worsening [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/32,49,58,61\" class=\"abstract_t\">32,49,58,61</a>]. Death may result from visceral disease or immunosuppressive therapy-related infections. Most individuals who improve have residual sensory and motor deficits.</p><p class=\"headingAnchor\" id=\"H23\"><span class=\"h3\">Autonomic neuropathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>An increased incidence of autonomic neuropathy, as determined by abnormal cardiovascular reflexes, has been reported [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/67\" class=\"abstract_t\">67</a>].</p><p class=\"headingAnchor\" id=\"H24\"><span class=\"h1\">NEUROMUSCULAR DISORDERS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Neuromuscular disorders are frequently found in rheumatoid arthritis (RA). Muscle weakness <span class=\"nowrap\">and/or</span> atrophy have been observed in approximately one-third of patients [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/68\" class=\"abstract_t\">68</a>]. Neuromuscular disorders include myopathy and myositis.</p><p class=\"headingAnchor\" id=\"H25\"><span class=\"h2\">Myopathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Myopathic processes, which are subdivided into disuse or denervation atrophy, must be distinguished from a muscular dystrophy, such as myopathy and weakness due to corticosteroid use.</p><p class=\"headingAnchor\" id=\"H26\"><span class=\"h3\">Disuse atrophy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Muscle weakness and wasting with disuse atrophy results from pain due to synovitis. Muscle biopsy reveals type II fiber atrophy; there is no muscle inflammation, necrosis, regeneration, or vasculitis [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/62,68-70\" class=\"abstract_t\">62,68-70</a>]. Effective treatment requires control of joint inflammation and reduction in pain, which is followed by a strengthening exercise program.</p><p class=\"headingAnchor\" id=\"H27\"><span class=\"h3\">Denervation atrophy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Motor nerve demyelination and degeneration due to angiopathic neuropathy, such as mononeuritis multiplex, can lead to muscle fiber atrophy, necrosis, and regeneration, with minimal muscle inflammation on biopsy [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/62,68\" class=\"abstract_t\">62,68</a>]. Treatment for weakness due to ischemia or infarction of peripheral nerve is directed at control of vasculitis (see <a href=\"topic.htm?path=treatment-of-rheumatoid-vasculitis\" class=\"medical medical_review\">&quot;Treatment of rheumatoid vasculitis&quot;</a>). If vasculitis is arrested, strength may recover slowly as remyelination and axonal regeneration occur.</p><p class=\"headingAnchor\" id=\"H28\"><span class=\"h3\">Muscular dystrophy-like myopathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Muscular dystrophy-like myopathy in those with RA is similar to muscular dystrophy both clinically and pathologically. There is loss of muscle tissue, replacement by adipose tissue, fiber caliber variation, and fibrosis without inflammatory infiltrates [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/62\" class=\"abstract_t\">62</a>]. Motor innervation is not disturbed. This may represent late chronic myositis.</p><p class=\"headingAnchor\" id=\"H29\"><span class=\"h3\">Glucocorticoid-induced myopathy</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Glucocorticoid-induced or steroid myopathy is characterized by proximal muscle weakness without significant serum muscle enzyme elevations. Muscle biopsy reveals type II fiber atrophy [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/70,71\" class=\"abstract_t\">70,71</a>]. Gradual reduction in the glucocorticoid dose and a muscle strengthening rehabilitation program are the mainstays of treatment. (See <a href=\"topic.htm?path=glucocorticoid-induced-myopathy\" class=\"medical medical_review\">&quot;Glucocorticoid-induced myopathy&quot;</a> and <a href=\"topic.htm?path=glucocorticoid-withdrawal\" class=\"medical medical_review\">&quot;Glucocorticoid withdrawal&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H30\"><span class=\"h2\">Myositis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>With myofiber necrosis and regeneration, there is focal or diffuse infiltration of lymphocytes, plasma cells, and mononuclear cells into the endomysium, perimysium, and perivascular areas [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/62,68,69,72\" class=\"abstract_t\">62,68,69,72</a>]. Since it may be impossible to distinguish myositis in RA from idiopathic polymyositis, this process may represent an overlap syndrome [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/9,62,68\" class=\"abstract_t\">9,62,68</a>].</p><p>One author has suggested that the pathologic abnormalities in rheumatoid myositis are less severe and patchier than those of polymyositis, and that RA patients tend to respond to lower <a href=\"topic.htm?path=prednisone-drug-information\" class=\"drug drug_general\">prednisone</a> doses than polymyositis patients [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/69\" class=\"abstract_t\">69</a>]. In this study, rheumatoid myositis was also associated with elevated serum creatine kinase levels, reflecting muscle fiber damage, and with disproportionately elevated erythrocyte sedimentation rates for the mild degree of synovitis.</p><p>Treatment of myositis complicating RA is similar to the therapy of idiopathic polymyositis. (See <a href=\"topic.htm?path=initial-treatment-of-dermatomyositis-and-polymyositis-in-adults\" class=\"medical medical_review\">&quot;Initial treatment of dermatomyositis and polymyositis in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H31\"><span class=\"h2\">Amyloid</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>RA may rarely be complicated by secondary amyloidosis, which may result in abnormalities in both the central and peripheral nervous systems [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/9\" class=\"abstract_t\">9</a>]. Amyloid deposits have been reported in brain arterioles in four patients with RA and central nervous system (CNS) vasculitis [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/10,11\" class=\"abstract_t\">10,11</a>]. Peripheral neuropathy can also result from secondary amyloidosis [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/9\" class=\"abstract_t\">9</a>]. (See <a href=\"topic.htm?path=causes-and-diagnosis-of-aa-amyloidosis-and-relation-to-rheumatic-diseases\" class=\"medical medical_review\">&quot;Causes and diagnosis of AA amyloidosis and relation to rheumatic diseases&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H32\"><span class=\"h1\">DRUGS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Medications utilized to treat rheumatoid arthritis (RA) are another major cause of neurologic complications [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/73\" class=\"abstract_t\">73</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Nonsteroidal antiinflammatory drugs (NSAIDs) may result in headaches, drowsiness, and aseptic meningitis. (See <a href=\"topic.htm?path=nonselective-nsaids-overview-of-adverse-effects\" class=\"medical medical_review\">&quot;Nonselective NSAIDs: Overview of adverse effects&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Glucocorticoids can cause myopathy, depression, psychosis, and benign intracranial hypertension. (See <a href=\"topic.htm?path=major-side-effects-of-systemic-glucocorticoids\" class=\"medical medical_review\">&quot;Major side effects of systemic glucocorticoids&quot;</a> and <a href=\"topic.htm?path=glucocorticoid-induced-myopathy\" class=\"medical medical_review\">&quot;Glucocorticoid-induced myopathy&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Antimalarials, such as <a href=\"topic.htm?path=hydroxychloroquine-drug-information\" class=\"drug drug_general\">hydroxychloroquine</a>, can cause dizziness, headache, tinnitus, seizures, and neuromyopathy. (See <a href=\"topic.htm?path=antimalarial-drugs-in-the-treatment-of-rheumatic-disease\" class=\"medical medical_review\">&quot;Antimalarial drugs in the treatment of rheumatic disease&quot;</a> and <a href=\"topic.htm?path=drug-induced-myopathies\" class=\"medical medical_review\">&quot;Drug-induced myopathies&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Gold therapy can be complicated by peripheral neuropathy, cranial nerve palsies, and Guillain-Barr&eacute; syndrome. (See <a href=\"topic.htm?path=major-side-effects-of-gold-therapy\" class=\"medical medical_review\">&quot;Major side effects of gold therapy&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=methotrexate-drug-information\" class=\"drug drug_general\">Methotrexate</a> can cause headaches and impair the ability to concentrate. (See <a href=\"topic.htm?path=major-side-effects-of-low-dose-methotrexate\" class=\"medical medical_review\">&quot;Major side effects of low-dose methotrexate&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=sulfasalazine-drug-information\" class=\"drug drug_general\">Sulfasalazine</a> and <a href=\"topic.htm?path=leflunomide-drug-information\" class=\"drug drug_general\">leflunomide</a> reportedly cause headaches. (See <a href=\"topic.htm?path=sulfasalazine-pharmacology-administration-and-adverse-effects-in-the-treatment-of-rheumatoid-arthritis\" class=\"medical medical_review\">&quot;Sulfasalazine: Pharmacology, administration, and adverse effects in the treatment of rheumatoid arthritis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=leflunomide-drug-information\" class=\"drug drug_general\">Leflunomide</a> is associated with peripheral neuropathy. (See <a href=\"topic.htm?path=pharmacology-dosing-and-adverse-effects-of-leflunomide-in-the-treatment-of-rheumatoid-arthritis\" class=\"medical medical_review\">&quot;Pharmacology, dosing, and adverse effects of leflunomide in the treatment of rheumatoid arthritis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Agents that interfere with the action of tumor necrosis factor alpha (anti-TNF therapies) may increase the risk of demyelinating disorders of the central nervous system (CNS) [<a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/74\" class=\"abstract_t\">74</a>]. Progressive multifocal leukoencephalopathy and peripheral neuropathy also have occurred in patients treated with anti-TNF therapies. (See <a href=\"topic.htm?path=overview-of-biologic-agents-and-kinase-inhibitors-in-the-rheumatic-diseases\" class=\"medical medical_review\">&quot;Overview of biologic agents and kinase inhibitors in the rheumatic diseases&quot;</a> and <a href=\"#H11\" class=\"local\">'Progressive multifocal leukoencephalopathy'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H1689845\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Neurologic abnormalities associated with rheumatoid arthritis (RA) can result from compression or infiltration of the spinal cord or nerves by rheumatoid synovitis and pannus and from rheumatoid vasculitis. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Disorders of the central nervous system (CNS) due to RA include cervical myelopathy, vasculitis, rheumatoid nodules located within the CNS, meningitis, organic brain syndrome (OBS), and, rarely, progressive multifocal leukoencephalopathy. Therapy of patients with RA and CNS vasculitis is similar to that for patients with isolated CNS vasculitis. (See <a href=\"#H2\" class=\"local\">'Central nervous system'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Stroke, particularly ischemic stroke, occurs with increased frequency, but the basis for this association is not well understood. (See <a href=\"#H13\" class=\"local\">'Stroke'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Compression neuropathies are the most common neurologic manifestation of RA. The most common entrapment neuropathy in RA is carpal tunnel syndrome, which is most likely due to finger-flexor tenosynovitis. Other syndromes due to nerve compression or entrapment include tarsal tunnel syndrome, due to compression of the posterior tibial nerve near the medial malleolus; syndromes affecting the anterior and posterior interosseous, ulnar, common peroneal, and tibial nerves; cervical nerve root compression; and common peroneal and tibial nerve compression from popliteal cysts. (See <a href=\"#H15\" class=\"local\">'Compression or entrapment neuropathy'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Noncompressive neuropathies include both distal sensory neuropathy, which is usually slowly progressive, and sensorimotor neuropathy, which may have a more acute presentation and which occurs in more severely affected patients with seropositive nodular disease and other extraarticular manifestations. These conditions may result from vasculopathy and vasculitis. An increased incidence of autonomic neuropathy may also be present in patients with RA. (See <a href=\"#H20\" class=\"local\">'Noncompression neuropathies'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Neuromuscular disorders are frequent in RA and may result in muscle weakness <span class=\"nowrap\">and/or</span> atrophy. These disorders include myopathy due to disuse or to denervation, which may be confused with myopathy due to glucocorticoids, and myositis, which is similar to polymyositis and which may represent part of an overlap syndrome. (See <a href=\"#H24\" class=\"local\">'Neuromuscular disorders'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Many of the medications used to treat RA, including nonsteroidal antiinflammatory drugs, glucocorticoids, and both traditional and biologic disease-modifying antirheumatic drugs (DMARDs), are associated with neurologic complications. (See <a href=\"#H32\" class=\"local\">'Drugs'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/1\" class=\"nounderline abstract_t\">Pu&eacute;chal X, Said G, Hilliquin P, et al. Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients. Arthritis Rheum 1995; 38:1618.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/2\" class=\"nounderline abstract_t\">Said G, Lacroix C. Primary and secondary vasculitic neuropathy. J Neurol 2005; 252:633.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/3\" class=\"nounderline abstract_t\">Scott DG, Bacon PA, Tribe CR. Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) 1981; 60:288.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/4\" class=\"nounderline abstract_t\">Makol A, Crowson CS, Wetter DA, et al. Vasculitis associated with rheumatoid arthritis: a case-control study. Rheumatology (Oxford) 2014; 53:890.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/5\" class=\"nounderline abstract_t\">Ward MM. Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983-2001. Arthritis Rheum 2004; 50:1122.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/6\" class=\"nounderline abstract_t\">Nyh&auml;ll-W&aring;hlin BM, Petersson IF, Jacobsson C, et al. Extra-articular manifestations in a community-based sample of patients with rheumatoid arthritis: incidence and relationship to treatment with TNF inhibitors. Scand J Rheumatol 2012; 41:434.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/7\" class=\"nounderline abstract_t\">Watts RA, Mooney J, Lane SE, Scott DG. Rheumatoid vasculitis: becoming extinct? Rheumatology (Oxford) 2004; 43:920.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/8\" class=\"nounderline abstract_t\">Beck DO, Corbett JJ. Seizures due to central nervous system rheumatoid meningovasculitis. Neurology 1983; 33:1058.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/9\" class=\"nounderline abstract_t\">Kim RC, Collins GH. The neuropathology of rheumatoid disease. Hum Pathol 1981; 12:5.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/10\" class=\"nounderline abstract_t\">Mandybur TI. Cerebral amyloid angiopathy: possible relationship to rheumatoid vasculitis. Neurology 1979; 29:1336.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/11\" class=\"nounderline abstract_t\">Ramos M, Mandybur TI. Cerebral vasculitis in rheumatoid arthritis. Arch Neurol 1975; 32:271.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/12\" class=\"nounderline abstract_t\">Singleton JD, West SG, Reddy VV, Rak KM. Cerebral vasculitis complicating rheumatoid arthritis. South Med J 1995; 88:470.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/13\" class=\"nounderline abstract_t\">STEINER JW, GELBLOOM AJ. Intracranial manifestations in two cases of systemic rheumatoid disease. Arthritis Rheum 1959; 2:537.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/14\" class=\"nounderline abstract_t\">Watson P. Intracranial hemorrhage with vasculitis in rheumatoid arthritis. Arch Neurol 1979; 36:58.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/15\" class=\"nounderline abstract_t\">Watson P, Fekete J, Deck J. Central nervous system vasculitis in rheumatoid arthritis. Can J Neurol Sci 1977; 4:269.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/16\" class=\"nounderline abstract_t\">Sigal LH. The neurologic presentation of vasculitic and rheumatologic syndromes. A review. Medicine (Baltimore) 1987; 66:157.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/17\" class=\"nounderline abstract_t\">Bekkelund SI, Pierre-Jerome C, Husby G, Mellgren SI. Quantitative cerebral MR in rheumatoid arthritis. AJNR Am J Neuroradiol 1995; 16:767.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/18\" class=\"nounderline abstract_t\">Bathon JM, Moreland LW, DiBartolomeo AG. Inflammatory central nervous system involvement in rheumatoid arthritis. Semin Arthritis Rheum 1989; 18:258.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/19\" class=\"nounderline abstract_t\">Takahashi M, Yamamoto J, Idei M, et al. Multiple intracranial nodules associated with rheumatoid arthritis: case report. Neurol Med Chir (Tokyo) 2014; 54:317.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/20\" class=\"nounderline abstract_t\">Friedman H. Intraspinal rheumatoid nodule causing nerve root compression. Case report. J Neurosurg 1970; 32:689.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/21\" class=\"nounderline abstract_t\">Hauge T, Magnaes B, L&oslash;ken AC, de Graaf AS. Treatment of rheumatoid pachymeningitis involving the entire thoracic region. Scand J Rheumatol 1978; 7:209.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/22\" class=\"nounderline abstract_t\">Contin JU, Oka M. Unusual cardiac, pulmonary and meningeal involvement in rheumatoid arthritis. Report of a case. Dis Chest 1966; 49:552.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/23\" class=\"nounderline abstract_t\">Jackson CG, Chess RL, Ward JR. A case of rheumatoid nodule formation within the central nervous system and review of the literature. J Rheumatol 1984; 11:237.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/24\" class=\"nounderline abstract_t\">Sunter JP. Rheumatoid disease with involvement of the leptomeninges presenting as symptomatic epilepsy. Beitr Pathol 1977; 161:194.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/25\" class=\"nounderline abstract_t\">Kim RC, Collins GH, Parisi JE. Rheumatoid nodule formation within the choroid plexus. Report of a second case. Arch Pathol Lab Med 1982; 106:83.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/26\" class=\"nounderline abstract_t\">Chowdhry V, Kumar N, Lachance DH, et al. An unusual presentation of rheumatoid meningitis. J Neuroimaging 2005; 15:286.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/27\" class=\"nounderline abstract_t\">Starosta MA, Brandwein SR. Clinical manifestations and treatment of rheumatoid pachymeningitis. Neurology 2007; 68:1079.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/28\" class=\"nounderline abstract_t\">Bourgeois P, Rivest J, Bocti C. Rheumatoid meningitis presenting with stroke-like episodes. Neurology 2014; 82:1564.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/29\" class=\"nounderline abstract_t\">Magaki S, Chang E, Hammond RR, et al. Two cases of rheumatoid meningitis. Neuropathology 2016; 36:93.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/30\" class=\"nounderline abstract_t\">Gupta VP, Ehrlich GE. Organic brain syndrome in rheumatoid arthritis following corticosteroid withdrawal. Arthritis Rheum 1976; 19:1333.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/31\" class=\"nounderline abstract_t\">Nakano KK. Neurologic complications of rheumatoid arthritis. Orthop Clin North Am 1975; 6:861.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/32\" class=\"nounderline abstract_t\">Fleischmann RM. Progressive multifocal leukoencephalopathy following rituximab treatment in a patient with rheumatoid arthritis. Arthritis Rheum 2009; 60:3225.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/33\" class=\"nounderline abstract_t\">Ray M, Curtis JR, Baddley JW. A case report of progressive multifocal leucoencephalopathy (PML) associated with adalimumab. Ann Rheum Dis 2014; 73:1429.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/34\" class=\"nounderline abstract_t\">Gonz&aacute;lez-Su&aacute;rez I, Aguilar-Amat MJ, Trigueros M, et al. Leukoencephalopathy due to oral methotrexate. Cerebellum 2014; 13:178.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/35\" class=\"nounderline abstract_t\">Furst DE, Keystone EC, Braun J, et al. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011. Ann Rheum Dis 2012; 71 Suppl 2:i2.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/36\" class=\"nounderline abstract_t\">Clifford DB, Ances B, Costello C, et al. Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol 2011; 68:1156.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/37\" class=\"nounderline abstract_t\">Molloy ES, Calabrese LH. Progressive multifocal leukoencephalopathy: a national estimate of frequency in systemic lupus erythematosus and other rheumatic diseases. Arthritis Rheum 2009; 60:3761.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/38\" class=\"nounderline abstract_t\">Zakzook SI, Yunus MB, Mulconrey DS. Hyperviscosity syndrome in rheumatoid arthritis with Felty's syndrome: case report and review of the literature. Clin Rheumatol 2002; 21:82.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/39\" class=\"nounderline abstract_t\">Avi&ntilde;a-Zubieta JA, Choi HK, Sadatsafavi M, et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 2008; 59:1690.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/40\" class=\"nounderline abstract_t\">Bacani AK, Gabriel SE, Crowson CS, et al. Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum 2012; 64:53.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/41\" class=\"nounderline abstract_t\">Nadareishvili Z, Michaud K, Hallenbeck JM, Wolfe F. Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case-control study. Arthritis Rheum 2008; 59:1090.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/42\" class=\"nounderline abstract_t\">Solomon DH, Goodson NJ, Katz JN, et al. Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 2006; 65:1608.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/43\" class=\"nounderline abstract_t\">Lindhardsen J, Ahlehoff O, Gislason GH, et al. Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. BMJ 2012; 344:e1257.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/44\" class=\"nounderline abstract_t\">Nakano KK. The entrapment neuropathies of rheumatoid arthritis. Orthop Clin North Am 1975; 6:837.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/45\" class=\"nounderline abstract_t\">Herbison GJ, Teng C, Martin JH, Ditunno JF Jr. Carpal tunnel syndrome in rheumatoid arthritis. Am J Phys Med 1973; 52:68.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/46\" class=\"nounderline abstract_t\">Muramatsu K, Tanaka H, Taguchi T. Peripheral neuropathies of the forearm and hand in rheumatoid arthritis: diagnosis and options for treatment. Rheumatol Int 2008; 28:951.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/47\" class=\"nounderline abstract_t\">Ogawa H, Akaike A, Ishimaru D, et al. Posterior interosseous nerve palsy related to rheumatoid synovitis of the elbow. Mod Rheumatol 2007; 17:327.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/48\" class=\"nounderline abstract_t\">Brick JE, Brick JF. Neurologic manifestations of rheumatologic disease. Neurol Clin 1989; 7:629.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/49\" class=\"nounderline abstract_t\">PALLIS CA, SCOTT JT. PERIPHERAL NEUROPATHY IN RHEUMATOID ARTHRITIS. Br Med J 1965; 1:1141.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/50\" class=\"nounderline abstract_t\">Barnes CG, Currey HL. Carpal tunnel syndrome in rheumatoid arthritis. A clinical and electrodiagnostic survey. Ann Rheum Dis 1967; 26:226.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/51\" class=\"nounderline abstract_t\">Chamberlain MA, Corbett M. Carpal tunnel syndrome in early rheumatoid arthritis. Ann Rheum Dis 1970; 29:149.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/52\" class=\"nounderline abstract_t\">Fleming A, Dodman S, Crown JM, Corbett M. Extra-articular features in early rheumatoid disease. Br Med J 1976; 1:1241.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/53\" class=\"nounderline abstract_t\">Chang DJ, Paget SA. Neurologic complications of rheumatoid arthritis. Rheum Dis Clin North Am 1993; 19:955.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/54\" class=\"nounderline abstract_t\">Hurd ER. Extraarticular manifestations of rheumatoid arthritis. Semin Arthritis Rheum 1979; 8:151.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/55\" class=\"nounderline abstract_t\">Baylan SP, Paik SW, Barnert AL, et al. Prevalence of the tarsal tunnel syndrome in rheumatoid arthritis. Rheumatol Rehabil 1981; 20:148.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/56\" class=\"nounderline abstract_t\">Grabois M, Puentes J, Lidsky M. Tarsal tunnel syndrome in rheumatoid arthritis. Arch Phys Med Rehabil 1981; 62:401.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/57\" class=\"nounderline abstract_t\">McGuigan L, Burke D, Fleming A. Tarsal tunnel syndrome and peripheral neuropathy in rheumatoid disease. Ann Rheum Dis 1983; 42:128.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/58\" class=\"nounderline abstract_t\">FERGUSON RH, SLOCUMB CH. Peripheral neuropathy in rheumatoid arthritis. Bull Rheum Dis 1961; 11:251.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/59\" class=\"nounderline abstract_t\">White SH, Goodfellow JW, Mowat A. Posterior interosseous nerve palsy in rheumatoid arthritis. J Bone Joint Surg Br 1988; 70:468.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/60\" class=\"nounderline abstract_t\">Bekkelund SI, Torbergsen T, Husby G, Mellgren SI. Myopathy and neuropathy in rheumatoid arthritis. A quantitative controlled electromyographic study. J Rheumatol 1999; 26:2348.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/61\" class=\"nounderline abstract_t\">Chamberlain MA, Bruckner FE. Rheumatoid neuropathy. Clinical and electrophysiological features. Ann Rheum Dis 1970; 29:609.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/62\" class=\"nounderline abstract_t\">Haslock DI, Wright V, Harriman DG. Neuromuscular disorders in rheumatoid arthritis. A motor-point muscle biopsy study. Q J Med 1970; 39:335.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/63\" class=\"nounderline abstract_t\">Weller RO, Bruckner FE, Chamberlain MA. Rheumatoid neuropathy: a histological and electrophysiological study. J Neurol Neurosurg Psychiatry 1970; 33:592.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/64\" class=\"nounderline abstract_t\">Conn DL, McDuffie FC, Dyck PJ. Immunopathologic study of sural nerves in rheumatoid arthritis. Arthritis Rheum 1972; 15:135.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/65\" class=\"nounderline abstract_t\">Goldman JA, Casey HL, McIlwain H, et al. Limited plasmapheresis in rheumatoid arthritis with vasculitis. Arthritis Rheum 1979; 22:1146.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/66\" class=\"nounderline abstract_t\">Lanzillo B, Pappone N, Crisci C, et al. Subclinical peripheral nerve involvement in patients with rheumatoid arthritis. Arthritis Rheum 1998; 41:1196.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/67\" class=\"nounderline abstract_t\">Edmonds ME, Jones TC, Saunders WA, Sturrock RD. Autonomic neuropathy in rheumatoid arthritis. Br Med J 1979; 2:173.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/68\" class=\"nounderline abstract_t\">Reza MJ, Verity MA. Neuromuscular manifestations of rheumatoid arthritis: A clinical and histomorphological analysis. Clin Rheum Dis 1977; 3:565.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/69\" class=\"nounderline abstract_t\">Halla JT, Koopman WJ, Fallahi S, et al. Rheumatoid myositis. Clinical and histologic features and possible pathogenesis. Arthritis Rheum 1984; 27:737.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/70\" class=\"nounderline abstract_t\">Haslock DI, Harriman DF, Wright V. Neuromuscular disorders associated with rheumatoid arthritis. Ann Rheum Dis 1970; 29:197.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/71\" class=\"nounderline abstract_t\">Askari A, Vignos PJ Jr, Moskowitz RW. Steroid myopathy in connective tissue disease. Am J Med 1976; 61:485.</a></li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/72\" class=\"nounderline abstract_t\">Wegelius O, Pasternack A, Kuhlb&auml;ck B. Muscular involvement in rheumatoid arthritis. Acta Rheumatol Scand 1969; 15:257.</a></li><li class=\"breakAll\">Rheumatology, 2nd, Klippel JH, Dieppe PA (Eds), Mosby, Philadelphia 1998.</li><li><a href=\"https://www.uptodate.com/contents/neurologic-manifestations-of-rheumatoid-arthritis/abstract/74\" class=\"nounderline abstract_t\">Kaltsonoudis E, Zikou AK, Voulgari PV, et al. Neurological adverse events in patients receiving anti-TNF therapy: a prospective imaging and electrophysiological study. Arthritis Res Ther 2014; 16:R125.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 7480 Version 14.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H1689845\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H687641716\" id=\"outline-link-H687641716\">CLASSIFICATION AND EPIDEMIOLOGY</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">CENTRAL NERVOUS SYSTEM</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Cervical myelopathy</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Central nervous system vasculitis</a><ul><li><a href=\"#H5\" id=\"outline-link-H5\">- Clinical manifestations</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">- Diagnosis</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">- Treatment</a></li></ul></li><li><a href=\"#H8\" id=\"outline-link-H8\">Rheumatoid nodules</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">Meningitis</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">Organic brain syndrome</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">Progressive multifocal leukoencephalopathy</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">Hyperviscosity syndrome</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">Stroke</a></li></ul></li><li><a href=\"#H14\" id=\"outline-link-H14\">PERIPHERAL NERVOUS SYSTEM</a><ul><li><a href=\"#H15\" id=\"outline-link-H15\">Compression or entrapment neuropathy</a><ul><li><a href=\"#H16\" id=\"outline-link-H16\">- Carpal tunnel syndrome</a></li><li><a href=\"#H17\" id=\"outline-link-H17\">- Tarsal tunnel syndrome</a></li><li><a href=\"#H18\" id=\"outline-link-H18\">- Other compression neuropathies</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">- Treatment of compression neuropathies</a></li></ul></li><li><a href=\"#H20\" id=\"outline-link-H20\">Noncompression neuropathies</a><ul><li><a href=\"#H21\" id=\"outline-link-H21\">- Distal sensory neuropathy</a></li><li><a href=\"#H22\" id=\"outline-link-H22\">- Combined sensorimotor neuropathy</a></li><li><a href=\"#H23\" id=\"outline-link-H23\">- Autonomic neuropathy</a></li></ul></li></ul></li><li><a href=\"#H24\" id=\"outline-link-H24\">NEUROMUSCULAR DISORDERS</a><ul><li><a href=\"#H25\" id=\"outline-link-H25\">Myopathy</a><ul><li><a href=\"#H26\" id=\"outline-link-H26\">- Disuse atrophy</a></li><li><a href=\"#H27\" id=\"outline-link-H27\">- Denervation atrophy</a></li><li><a href=\"#H28\" id=\"outline-link-H28\">- Muscular dystrophy-like myopathy</a></li><li><a href=\"#H29\" id=\"outline-link-H29\">- Glucocorticoid-induced myopathy</a></li></ul></li><li><a href=\"#H30\" id=\"outline-link-H30\">Myositis</a></li><li><a href=\"#H31\" id=\"outline-link-H31\">Amyloid</a></li></ul></li><li><a href=\"#H32\" id=\"outline-link-H32\">DRUGS</a></li><li><a href=\"#H1689845\" id=\"outline-link-H1689845\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=antimalarial-drugs-in-the-treatment-of-rheumatic-disease\" class=\"medical medical_review\">Antimalarial drugs in the treatment of rheumatic disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=carpal-tunnel-syndrome-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Carpal tunnel syndrome: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=carpal-tunnel-syndrome-etiology-and-epidemiology\" class=\"medical medical_review\">Carpal tunnel syndrome: Etiology and epidemiology</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=carpal-tunnel-syndrome-treatment-and-prognosis\" class=\"medical medical_review\">Carpal tunnel syndrome: Treatment and prognosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=causes-and-diagnosis-of-aa-amyloidosis-and-relation-to-rheumatic-diseases\" class=\"medical medical_review\">Causes and diagnosis of AA amyloidosis and relation to rheumatic diseases</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cervical-subluxation-in-rheumatoid-arthritis\" class=\"medical medical_review\">Cervical subluxation in rheumatoid arthritis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-rheumatoid-vasculitis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of rheumatoid vasculitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=coronary-artery-disease-in-rheumatoid-arthritis-pathogenesis-risk-factors-clinical-manifestations-and-diagnostic-implications\" class=\"medical medical_review\">Coronary artery disease in rheumatoid arthritis: Pathogenesis, risk factors, clinical manifestations, and diagnostic implications</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-and-treatment-of-vasculitic-neuropathy\" class=\"medical medical_review\">Diagnosis and treatment of vasculitic neuropathy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=drug-induced-myopathies\" class=\"medical medical_review\">Drug-induced myopathies</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-pathogenesis-clinical-manifestations-and-diagnosis-of-waldenstrom-macroglobulinemia\" class=\"medical medical_review\">Epidemiology, pathogenesis, clinical manifestations, and diagnosis of Waldenstr&ouml;m macroglobulinemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=glucocorticoid-withdrawal\" class=\"medical medical_review\">Glucocorticoid withdrawal</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=glucocorticoid-induced-myopathy\" class=\"medical medical_review\">Glucocorticoid-induced myopathy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=initial-treatment-of-dermatomyositis-and-polymyositis-in-adults\" class=\"medical medical_review\">Initial treatment of dermatomyositis and polymyositis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=major-side-effects-of-gold-therapy\" class=\"medical medical_review\">Major side effects of gold therapy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=major-side-effects-of-low-dose-methotrexate\" class=\"medical medical_review\">Major side effects of low-dose methotrexate</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=major-side-effects-of-systemic-glucocorticoids\" class=\"medical medical_review\">Major side effects of systemic glucocorticoids</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nonselective-nsaids-overview-of-adverse-effects\" class=\"medical medical_review\">Nonselective NSAIDs: Overview of adverse effects</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-jc-polyomavirus-bk-polyomavirus-and-other-polyomavirus-infections\" class=\"medical medical_review\">Overview of JC polyomavirus, BK polyomavirus, and other polyomavirus infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-biologic-agents-and-kinase-inhibitors-in-the-rheumatic-diseases\" class=\"medical medical_review\">Overview of biologic agents and kinase inhibitors in the rheumatic diseases</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-the-systemic-and-nonarticular-manifestations-of-rheumatoid-arthritis\" class=\"medical medical_review\">Overview of the systemic and nonarticular manifestations of rheumatoid arthritis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pharmacology-dosing-and-adverse-effects-of-leflunomide-in-the-treatment-of-rheumatoid-arthritis\" class=\"medical medical_review\">Pharmacology, dosing, and adverse effects of leflunomide in the treatment of rheumatoid arthritis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=popliteal-bakers-cyst\" class=\"medical medical_review\">Popliteal (Baker's) cyst</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=primary-angiitis-of-the-central-nervous-system-in-adults\" class=\"medical medical_review\">Primary angiitis of the central nervous system in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=progressive-multifocal-leukoencephalopathy-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Progressive multifocal leukoencephalopathy: Epidemiology, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=rituximab-and-other-b-cell-targeted-therapies-for-rheumatoid-arthritis\" class=\"medical medical_review\">Rituximab and other B cell targeted therapies for rheumatoid arthritis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=sulfasalazine-pharmacology-administration-and-adverse-effects-in-the-treatment-of-rheumatoid-arthritis\" class=\"medical medical_review\">Sulfasalazine: Pharmacology, administration, and adverse effects in the treatment of rheumatoid arthritis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=surgery-for-carpal-tunnel-syndrome\" class=\"medical medical_review\">Surgery for carpal tunnel syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-rheumatoid-vasculitis\" class=\"medical medical_review\">Treatment of rheumatoid vasculitis</a></li></ul></div></div>","javascript":null}